Your browser doesn't support javascript.
loading
Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction.
Wehmeyer, Corinna; Frank, Svetlana; Beckmann, Denise; Böttcher, Martin; Cromme, Christoph; König, Ulrich; Fennen, Michelle; Held, Annelena; Paruzel, Peter; Hartmann, Christine; Stratis, Athanasios; Korb-Pap, Adelheid; Kamradt, Thomas; Kramer, Ina; van den Berg, Wim; Kneissel, Michaela; Pap, Thomas; Dankbar, Berno.
Afiliação
  • Wehmeyer C; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Frank S; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Beckmann D; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Böttcher M; Institute of Immunology, University Hospital Jena, 07743 Jena, Germany.
  • Cromme C; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • König U; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Fennen M; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Held A; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Paruzel P; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Hartmann C; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Stratis A; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Korb-Pap A; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
  • Kamradt T; Institute of Immunology, University Hospital Jena, 07743 Jena, Germany.
  • Kramer I; Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
  • van den Berg W; Nijmegen Centre for Molecular Life Sciences, 86525 Nijmegen, Netherlands.
  • Kneissel M; Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
  • Pap T; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany. thomas.pap@uni-muenster.de.
  • Dankbar B; Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, 48149 Muenster, Germany.
Sci Transl Med ; 8(330): 330ra35, 2016 Mar 16.
Article em En | MEDLINE | ID: mdl-27089204
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas / Fator de Necrose Tumoral alfa / Proteínas Morfogenéticas Ósseas / Inflamação / Articulações Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas / Fator de Necrose Tumoral alfa / Proteínas Morfogenéticas Ósseas / Inflamação / Articulações Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article